A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension

Clinical trial NCT02059616 · UNKNOWN

Trial details

NCT number: NCT02059616
Sponsor: HK inno.N Corporation
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2014-02-01
Primary completion: 2015-06-01
Enrollment: 384

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.